Thursday, October 19th | 29 Tishri 5778

Close

Be in the know!

Get our exclusive daily news briefing.

Subscribe
August 2, 2017 2:22 pm

Hebrew University to Host Prestigious Medical Cannabis Conference in 2021

avatar by JNS.org

Email a copy of "Hebrew University to Host Prestigious Medical Cannabis Conference in 2021" to a friend

Medical cannabis at Israel’s third annual CannaTech conference in March 2017. Photo: Adam Abrams.

JNS.org – The International Cannabinoid Research Society (ICRS) will hold its global conference at Israel’s Hebrew University of Jerusalem in 2021.

The ICRS — the oldest scientific society devoted to the study of cannabis — convenes annually and has some 400 members around the world.

Previous conferences by the group have focused on using cannabis-based medicines to treat autoimmune disorders, epilepsy, pain, PTSD, metabolism, obesity, cancer and other ailments.

The society’s 2021 International Symposium on the Cannabinoids in Jerusalem will host hundreds of Israeli and international participants at the Jerusalem International Convention Center.

Related coverage

October 19, 2017 11:37 am
0

Israeli PM Netanyahu Calls Russian President Putin to Discuss Syria Conflict Amid Rise in Tensions

JNS.org - Israeli Prime Minister Benjamin Netanyahu called Russian President Vladimir Putin on Wednesday to discuss the conflict in Syria, just...

Hebrew University’s Multidisciplinary Center on Cannabinoid Research will host the conference.

“[Israeli] Prof. Raphael Mechoulam was the first to publish the structure of the active principal of cannabis, THC, and was also the first to identify an endogenous cannabinoid, anandamide,” noted ICRS Executive Director Prof. Cecilia Hillard, the Jerusalem Post reported.

“Just as impressive is the current state of cannabinoid research in Jerusalem and Israel at large, including the Multidisciplinary Center on Cannabinoid Research led by Dr. Joseph Tam,” she added. “We are looking forward to visiting Jerusalem and to an exciting and informative conference.”

Share this Story: Share On Facebook Share On Twitter Email This Article

Let your voice be heard!

Join the Algemeiner

Algemeiner.com